8:30-9:15AM — Case Presentations: Retina (Dr. Frank Brodie)

9:15-10:00AM — Grand Rounds Lecture: “New Frontiers in Retinal Gene Therapy: From Voretigene to Base Editing”,
Dr. Aaron Nagiel, PhD, MD

1. To understand basis of retinal gene therapy.
2. Understand landscape of retinal gene therapy trials.
3. Identify future treatment modalities such as base editing.

Disclosures:  Presenter Dr. Aaron Nagiel, PhD, MD has the following financial relationships to disclose:
CRISPR Tx – Equity and Janssen, Ultragenyx, Lexitas and Immuneering – Consultant.
Planner Yvonne Ou, MD, has received research funding from Astellas Institute for Regenerative Medicine and advises for Oculinea and Janssen.

Target Audience: Physicians and Advanced Practice Providers.

Accreditation: In support of improving patient care, UCSF Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation: UCSF designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This presentation receives support from UCSF’s (non-commercial) Samuel J. Kimura Fund, Transamerica Lecture Fund and Proctor Lecture Fund.